HappeningToo topic
Ondansetron Hydrochloride reports
Browse community reports connected to Ondansetron Hydrochloride. These reports can show that other people are describing similar experiences, but they do not prove that Ondansetron Hydrochloride caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
40 problems
Abdominal Discomfort while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and abdominal discomfort appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and abdominal distension appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and abdominal pain upper appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and abdominal pain appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and alopecia appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and anxiety appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and back pain appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chest Discomfort while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and chest discomfort appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and chills appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and constipation appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and cough appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and decreased appetite appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and dehydration appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and diarrhea appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and dizziness appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and excessive sweating appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and fatigue appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and feeling abnormal appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and headache appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and hypotension appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and insomnia appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and itching appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and malaise appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and muscle spasms appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and muscular weakness appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and myalgia appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and nausea appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and pain appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and peripheral swelling appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and rash appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and shortness of breath appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and skin redness appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and sleepiness appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tachycardia while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and tachycardia appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and tingling or pins and needles appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and tremor appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and vomiting appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and weakness appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and weight decreased appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Ondansetron Hydrochloride
FDA FAERS contains adverse-event reports in which Ondansetron Hydrochloride and weight increased appear together. This does not establish that Ondansetron Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →